bromodeoxyuridine has been researched along with 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, K; Fukunaga, K; Ishizaka, A; Nakajima, T; Niimi, K; Oguma, T; Shiomi, T; Shiraishi, Y; Suzuki, Y; Yamaguchi, K | 1 |
1 other study(ies) available for bromodeoxyuridine and 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid
| Article | Year |
|---|---|
Human bronchial smooth muscle cell proliferation via thromboxane A2 receptor.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Bromodeoxyuridine; Bronchi; Cell Proliferation; Cells, Cultured; Epidermal Growth Factor; Fatty Acids, Unsaturated; Humans; Intracellular Signaling Peptides and Proteins; Muscle, Smooth; Phosphorylation; Protein-Tyrosine Kinases; Receptors, Thromboxane A2, Prostaglandin H2 | 2004 |